Renal renin secretion is regulated by numerous physiological factors which act in a direct or indirect fashion through alterations in hemodynamic or circulatory factors. Renin release studies using renal cortical slices have been reported in the rat, rabbit, dog, pig, and recently in the mouse of examine the direct stimuli on juxtaglomerullar cells not mediated by systemic effects. However, the evaluations of some of the essential characters of the experimental system, e.g., energy dependency (1, 2), Ca dependency (2-4), and oxygen demand (5, 6) of renin secretion show discrepancies in some of the studies. Me thodological problems seems to be involved in some of the inconsistencies in the experi mental results. Renin determination in many studies have been performed through angiotensin I radioimmunoassay since Haber et al. (7) . Commercially available angiotensin I radioimmunoassay kits are, however, expensive and sometimes insufficient in the sensitivity for various pharmacological studies. In the present paper, we will describe the preparation of anti-angiotensin I anti serum, the determination of renin activity released from dog renal cortical slices by radioimmunoassay of angiotensin I, and adrenergic 3-receptor mediated renin release using this experimental system.
For the primary and secondary immuni zation, angiotensin I antigen was synthesized by mixing 10 mg each of angiotensin I (Sigma, A9650: Isoleucine5 angiotensin I) and bovine serum albumin in 0.5 ml of water and then adding of 1-ethyl -3-(3-dimethyl aminopropyl) carbodiimide HCI (EDC) (150 mg) in 0.5 ml of water. After 30 min standing at room temperature, the remarkably ag gragated reaction mixture was dialyzed against distilled water, lyophilized and kept until use. Five mg of the conjugate was dispersed by sonication in saline (1 ml), emulsified with an equal volume of Freund's complete adjuvant, and injected into two male rabbits in two thigh sites (i.m.) and three sites on the back (s.c.). Three booster injections were performed three, eight, and seventeen months after the primary injection. In the antigen synthesis for the third and fourth injections, the amount of EDC was reduced to 10 mg and 50 mg, respectively. Selection of antiserum for a sensitive radioimmunoassay was performed by examining the 1251 angiotensin I binding capacity curves of the antisera at a dilution-fold of 50% binding. As shown in Table 1 , a dissociation between high titer and high sensitivity was observed. All antisera obtained after the third immuni zation were available for an angiotensin I radioimmunoassay in this study. Specificity of these antisera were examined by determi nation of the cross-reactivities of angiotensin II and angiotensin III. These peptides showed negligible cross-reactivities (<0.001 %). Angiotensinogen (dog), which may possess the antigenic structure of angiotensin I on the molecule, was expected to cross-react against anti-angiotensin I antiserum; but in actuality, this cross-reaction was negligible in the concentration used in this experimental system. The radioimmunoassay procedure was as follows: each assay mixture consisted of 0.1 ml of sample solution; 1251-angiotensin I (New England Nuclear, NEX-101) (about 0.01 iiCi); diluted antiserum; and 0.5 ml of 0.05 M sodium phosphate buffer, pH 7.5, containing 0.03 M EDTA, 0.1% NaN3, and 0.1% of bovine serum albumin. These assay mixtures were stood overnight at 4°C after mixing. Then at 0°C, 0.4 ml of Dextran-coated charcoal suspension was added to each tube, mixed, and centrifuged at 3000 rpm at 4°C for 20 min. The supernatant (0.8 ml) was transferred to another tube, and radioactivity was counted in a autowell gamma counter. Dog renin substrate was prepared from pentobarbital anesthetized dogs. During 8 hr, the bilateral renal arteries, veins, and ureters were completely occluded. Thereafter, blood was slowly drawn from the carotid or brachial artery after the intravenous injection of 100 U/kg of heparin. Angiotensinogen was isolated through differential ammonium sulfate precipitation of the plasma according to the modified methods of Prinz et al. (8) . The dog renin substrate contained about 400 to 500 ng angiotensin I equivalent per ml of original plasma. Intrinsic renin could not removed completely by this preparation method.
For the preparation of kidney slices, kidney were isolated from pentobarbital anesthetized mongrel dogs. The kidneys were placed in ice cold saline and perfused with ice cold physiological salt solution until the effluent from the vein became clean. The renal capsule was removed, and the kidney was bisected along the longitudinal axis. Renal cortical slices (thickness 0.3-0.5 mm) were made transversly with a Stadie-Riggs slicer. Two slices were combined in a 20 ml Erlenmeyer flask containing 2 ml of Krebs Henseleit, 0.2% glucose buffer.
Incubation was performed at 37°C with gentle shaking (Taiyo Monosin-II A, 100 shakes/min) under a stream of 95%02-5% CO2. After 30 min preincubation, the buffer was rapidly aspirated and replaced with a fresh buffer before starting the test period. During the incubation period, 100 ul of medium was removed at 30 min and 60 min for renin analysis; and the tissue from each flask was blotted dry and weighed (100-150 mg/flask). The renin samples were cen trifuged at 4°C, and the supernatant fluids were quickly frozen and stored at -20°C until analyzed.
The renin levels were measured by determi nation of the angiotensin I produced after incubation with angiotensinogen. The angio tensin I generating system was composed of phosphate buffer, pH 6, containing 10-2 M EDTA, 3.42 x 10-4 M dimercaprol, 1.63x10-3 M diisopropyl fluorophosphate, 1.14X10-3 M 8-hydroxyquinoline, and dog renin substrate (about 100 ng as the angiotensin equivalent). Dimercaprol and diisopropyl fluorophosphate were added as isopropanol solutions. The mixture was incubated at 37°C for 2 hr. The reaction was terminated by dilution at 0°C with 2 ml of an ice cold radioimmunoassay buffer. After adequate dilution, 100 PI was taken for radioimmuno assay. The quantity of angiotensin I generated was derived from a standard curve and used to calculate renin activity in the slice incu bation medium. Because dog renin substrate contained some intrinsic renin activity (about 1 % of the total angiotensin I equivalent), the value was subtracted as the extrinsic renin blank from the amount of angiotensin I produced during the incubation period. Values were represented as ng angiotensin I produced/hr/mg tissue.
In the present experimental system, 1 isoproterenol-induced renin release was examined. The direct effect of e9-adrenergic stimulation on renin release was first reported in rat renal cortical slices by Weinberger et al. (9) . They found that catecholamines were protected from degradation by the addition of ascorbic acid. In our experiment, I-isopro terenol (4X10-6 M) failed to induce a statistically significant stimulation of renin release in the absence of ascorbic acid: control, 100+10.64% (n=16, mean±S.E.M.) and 1-isoproterenol, 126.9+15.9% (n=16, 0.05<P<0.1 compared with control) for a 30 min incubation period. However, I isoproterenol did elicit a significant increase of the control with ascorbic acid (10-5 M), and the isoproterenol-induced renin release was blocked with d,l-propranolol (1. The effect of ascorbic acid on renin release was evaluated by adding it to the control medium. Ascorbic acid (10-5 M) alone had no effect on renin release. This effect might be due to the prevention of isoproterenol degradation by its anti-oxidant action.
Thus, the renin release mediated by intra renal cortical (3-adrenergic receptors was confirmed.
Since stimulation of (3-adrenergic receptors activate adenylate cyclase in many tissues which leads to an increase in the intracellular concentration of cyclic adenosine 3',5' monophosphate (cyclic AMP), the role of cyclic AMP in renin release has been studied in vivo and in vitro. However, there have been some conflicting reports concerning the effect of dibutyryl cyclic AMP on renin release in vitro. Yamamoto et al. observed a biphasic effect of dibutyryl cyclic AMP (10-5, 10-4, and 10-3 M) on renin release from dog renal cortical slices, a 20% increase in 30 min and later inhibition (10) . We also examined the effect of dibutyryl cyclic AMP on renin release from dog renal cortical slices. As shown in Fig. 1 , the renin release was stimulated with dibutyryl cyclic AMP dose and time dependently. The divergent effects are puzzling. Some methodological differ ences might account for the contradictory observations.
In the studies using renal cortical slices, the involvement of prostaglandins had not been considered until direct stimulation of renin release by prostacyclin was reported in rabbit renal cortical slices (11, 12) . Recently, in the rat (13) and mouse (14) , studies were perfomed on prostacyclin stimulated renin release in renal slice experimental systems. Dog renal microsomes showed significant prostacyclin synthetic activity (15) . The spontaneous renin release from dog renal cortical slices was significantly inhibited with 10-5 M indomethacin: control, 100± 6.57% (n=8) and indomethacin, 66.1±4.6%
(n=8, P<0.001) during an incubation time of 60 min. These facts may suggest the involvement of prostaglandins in the spon taneous renin release from slices. However, the possibility can not be excluded that the inhibition of renin release by indomethacin is unrelated to inhibition of prostaglandin cyclooxygenase.
In the present study, we determined active renin through radioimmunoassay of the amount of produced angiotensin I, but a further desirable approach to the precise examination of renin secretion is both a measurement of active and inactive renin. In the slice incubation system, active renin response does not always mean total renin response (14, 16, 17) .
